Aytu BioPharma (AYTU) Financial Statements & Analysis

Aytu BioPharma Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Aytu BioPharma, Inc. income statement - Annual data in millions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Jun 2026	Jun 2025	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Sep 2020	Jun 2019	Jun 2018	Jun 2017
Revenue & Gross Profit
Revenue	57.57	66.38	65.18	107.40	96.67	65.63	27.63	7.32	3.66	3.22
Cost of Revenue	20.75	20.55	16.13	40.77	44.39	36.43	8.28	2.20	2.05	1.42
Gross Profit	36.82	45.83	49.05	66.63	52.28	29.20	19.35	5.12	1.61	1.80
Operating Expenses
Research & Development	0.00	1.33	2.77	4.10	12.66	5.62	1.72	0.59	0.17	1.35
Selling, General & Administrative	42.64	38.29	42.04	70.08	69.88	55.81	31.06	19.24	17.73	17.61
Operating Expenses	45.13	53.66	48.49	83.70	88.39	88.07	40.48	21.96	19.45	20.66
Operating Income	-8.32	-7.83	0.57	-17.07	-36.10	-58.87	-21.13	-16.85	-19.70	-20.13
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00
Interest Expense	1.90	-3.70	5.06	4.96	-0.01	0.00	0.00	0.00	0.75	2.53
Other Income/Expense	-4.02	-5.92	-5.88	0.01	-72.79	0.84	7.51	-10.29	9.51	-2.38
Income
Income Before Tax	-14.23	-13.75	-10.38	-17.05	-108.89	-58.03	-13.62	-27.13	-10.19	-22.51
Income Tax Expense	0.02	-0.44	2.14	0.00	-0.11	0.26	0.00	20.04	0.00	0.00
Net Income	-14.25	-13.56	-15.84	-17.05	-108.78	-58.29	-13.62	-47.17	-10.19	-22.51
Net Income - Continuous Operations	-14.25	-14.18	-12.52	-17.05	-108.78	-58.29	-13.62	-47.17	-10.19	-22.51
Net Income - Discontinued Operations	-	0.62	-3.32	-	-	-	-	-	-	-
EBITDA	-4.39	7.91	1.41	-3.27	-25.96	-29.04	-12.21	-14.61	-15.25	-18.13
EBIT	-8.32	2.54	-5.32	-5.21	-36.10	-38.24	-	-	-	-
Depreciation & Amortization	2.49	5.38	3.68	8.82	5.84	9.20	5.71	2.24	1.85	1.84
Earnings Per Share
Basic EPS	-1.00	-2.00	-3.00	-5.00	-75.00	-70.00	-60.00	-1210.00	-3061.00	-193194.00
Diluted EPS	-1.00	-2.00	-3.00	-5.00	-75.00	-70.00	-60.00	-1210.00	-3061.00	-193194.00
Basic Shares Outstanding	12.32	6.28	5.54	3.34	1.47	0.84	0.23	0.04	0.00	0.00
Diluted Shares Outstanding	12.32	6.28	5.54	3.34	1.47	0.84	0.23	0.04	0.00	0.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Aytu BioPharma Financial Statements

What was Aytu BioPharma's revenue in fiscal 2026?

Aytu BioPharma reported revenue of $57.57M in fiscal 2026 (fiscal year ended Jun 30, 2026). That was down 13.3% from $66.38M a year earlier.

Is Aytu BioPharma profitable?

No. Aytu BioPharma reported a net loss of $14.25M in fiscal 2026. In fiscal 2025 it lost $13.56M.

What is Aytu BioPharma's operating margin?

Aytu BioPharma's operating income was −$8.31M on revenue of $57.57M in fiscal 2026, an operating margin of -14.4%, compared with -11.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition